Literature DB >> 30002117

Fresh approaches to vaccine development: New financial and economic models are required to bring more vaccines against a wider range of diseases to the market.

Adam Gristwood1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 30002117      PMCID: PMC6073068          DOI: 10.15252/embr.201846675

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  7 in total

1.  Establishing a Global Vaccine-Development Fund.

Authors:  Stanley A Plotkin; Adel A F Mahmoud; Jeremy Farrar
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

2.  Emerging infectious diseases: A proactive approach.

Authors:  David E Bloom; Steven Black; Rino Rappuoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

3.  Prioritizing vaccines for developing world diseases.

Authors:  Allan Saul; Katherine L O'Brien
Journal:  Vaccine       Date:  2016-12-22       Impact factor: 3.641

4.  Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Authors:  Steven M Jones; Heinz Feldmann; Ute Ströher; Joan B Geisbert; Lisa Fernando; Allen Grolla; Hans-Dieter Klenk; Nancy J Sullivan; Viktor E Volchkov; Elizabeth A Fritz; Kathleen M Daddario; Lisa E Hensley; Peter B Jahrling; Thomas W Geisbert
Journal:  Nat Med       Date:  2005-06-05       Impact factor: 53.440

5.  Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Authors:  Ana Maria Henao-Restrepo; Ira M Longini; Matthias Egger; Natalie E Dean; W John Edmunds; Anton Camacho; Miles W Carroll; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Stefanie Hossmann; Mandy Kader Kondé; Souleymane Kone; Eeva Kuisma; Myron M Levine; Sema Mandal; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; Conall H Watson; Sakoba Kéïta; Marie Paule Kieny; John-Arne Røttingen
Journal:  Lancet       Date:  2015-08-03       Impact factor: 79.321

6.  A global biomedical R&D fund and mechanism for innovations of public health importance.

Authors:  Manica Balasegaram; Christian Bréchot; Jeremy Farrar; David Heymann; Nirmal Ganguly; Martin Khor; Yves Lévy; Precious Matsoso; Ren Minghui; Bernard Pécoul; Liu Peilong; Marcel Tanner; John-Arne Røttingen
Journal:  PLoS Med       Date:  2015-05-11       Impact factor: 11.069

7.  Preparing for the next Zika.

Authors:  Kendall Hoyt; Richard Hatchett
Journal:  Nat Biotechnol       Date:  2016-04       Impact factor: 54.908

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.